Comparison of Clinical Trial Changes in Primary Outcome and Reported Intervention Effect Size Between Trial Registration and Publication

被引:35
|
作者
Chen, Tao [2 ]
Li, Chao [1 ,2 ]
Qin, Rui [3 ]
Wang, Yang [4 ,5 ]
Yu, Dahai [6 ]
Dodd, James [2 ]
Wang, Duolao [2 ]
Cornelius, Victoria [7 ]
机构
[1] Xi An Jiao Tong Univ, Sch Publ Hlth, Hlth Sci Ctr, Dept Epidemiol & Hlth Stat, Xian 710061, Peoples R China
[2] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Trop Clin Trials Unit, Liverpool L3 5QA, Merseyside, England
[3] Jiangsu Prov Hosp Integrat Chinese & Western Med, Dept Hlth Educ, Nanjing, Jiangsu, Peoples R China
[4] Peking Union Med Coll, Med Res & Biometr Ctr, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Beijing, Peoples R China
[6] Keele Univ, Arthrit Res UK Primary Care Ctr, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England
[7] Imperial Coll London, Sch Publ Hlth, Imperial Clin Trials Unit, London, England
关键词
RANDOMIZED CONTROLLED-TRIALS; PUBLISHED PRIMARY OUTCOMES; END-POINTS; CONCLUSIONS; QUALITY;
D O I
10.1001/jamanetworkopen.2019.7242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Primary outcome change could threaten the validity of a clinical trial; however, evidence about the consequences on the reported intervention effect size is unclear. OBJECTIVES To examine the status of randomized clinical trials whose primary outcome changed between trial registration and publication and to quantify the association of this change with the reported intervention effect size. DESIGN, SETTING, AND PARTICIPANTS In this cross-sectional study on the primary report of randomized clinical trials with clear prospectively registered primary outcomes, PubMed and Embase were searched for articles published between January 1, 2011, and December 31, 2015. The search was conducted in January 2016, identifying randomized clinical trials and the combination of keywords and text words related to registry. MAIN OUTCOMES AND MEASURES Based on the developed approach, trials were classified as having primary outcome change when there was a major discrepancy between the registered and published primary outcomes. Intervention effect was estimated or recalculated using the odds ratio (OR) for each comparison. Each component OR is structured so that an OR is less than 1 if the intervention group has a more favorable result than the control group. The ratio of ORs (ROR), which is the summary OR for trials with primary outcome change divided by those without, and its 95% CI were calculated, with a value less than 1 indicating a larger reported intervention effect size in trials with primary outcome change than those without. RESULTS Among 29 749 searched articles (28 810 MEDLINE and 939 Embase), 1488 articles were randomly selected for review. Of 389 trials with clear primary outcomes prospectively described in the registry (416 outcomes reported), 33.4% (130 of 389) of trials had at least 1 primary outcome change. Most (66 of 130) of the changes were either not reporting or omitting the primary outcome. In total, 338 trials (365 outcomes and 487 comparisons) were available for quantitative analysis on the reported intervention effect size bias assessment. Compared with those without primary outcome change, trials with primary outcome change showed a 16% (pooled ROR, 0.84; 95% CI, 0.73-0.96) larger reported intervention effect size. The result persisted after adjustment for potential confounders (ROR, 0.81; 95% CI, 0.71-0.93) and other sensitivity and subgroup analyses. CONCLUSIONS AND RELEVANCE Results of this study suggest that inconsistencies between registered and published primary outcomes of clinical trials are common, and trials with primary outcome change are likely to have a larger intervention effect than those without.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] OVERALL PROGNOSIS AS THE PRIMARY CRITERION OF OUTCOME IN A CLINICAL-TRIAL
    MIETTINEN, OS
    ELLISON, RC
    PECKHAM, GJ
    KRAYBILL, EN
    BREART, GL
    NADAS, AS
    CONTROLLED CLINICAL TRIALS, 1983, 4 (03): : 227 - 237
  • [32] Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results
    Haas, JS
    Kaplan, CP
    Gerstenberger, EP
    Kerlikowske, K
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (03) : 184 - 188
  • [33] Effycacy of an Educational Intervention Group on Changes in Lifestyles in Hypertensive Patients in Primary Care: A Randomized Clinical Trial
    Rodriguez Martin, Carmela
    Castano Sanchez, Carmen
    Garcia Ortiz, Luis
    Recio Rodriguez, Jose Ignacio
    Castano Sanchez, Yolanda
    Gomez Marcos, Manuel Angel
    REVISTA ESPANOLA DE SALUD PUBLICA, 2009, 83 (03): : 441 - 452
  • [34] GENDER AND SCHIZOPHRENIA OUTCOME - A CLINICAL-TRIAL OF AN INPATIENT FAMILY INTERVENTION
    HAAS, GL
    GLICK, ID
    CLARKIN, JF
    SPENCER, JH
    LEWIS, AB
    SCHIZOPHRENIA BULLETIN, 1990, 16 (02) : 277 - 292
  • [35] Prospective trial registration and publication rates of randomized clinical trials in digital health: A cross-sectional analysis of global trial registries
    Al-Durra, Mustafa
    Nolan, Robert P.
    Seto, Emily
    Cafazzo, Joseph A.
    DIGITAL HEALTH, 2022, 8
  • [36] Random clinical trial to evaluate the effect of a multimodal intervention in hand hygiene in primary care in Madrid
    A Cañada
    Carmen Martín
    Sonia Soto
    Juan Carlos Abánades
    Miguel Salinero
    BMC Proceedings, 5 (Suppl 6)
  • [37] Comparison of Primary Percutaneous Coronary Intervention in Real-World Populations Versus Clinical Trial Populations
    Jakobsen, Lars
    Niemann, Troels
    Pedersen, Niels T.
    Nielsen, Torsten T.
    Johnsen, Soren P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (12): : 1684 - 1691
  • [38] A treatment analysis tool for clinical, dosimetric and outcome data reported in the EMBRACE trial
    Ecker, S.
    Kirisits, C.
    Seppenwoolde, Y.
    Tanderup, K.
    De Leeuw, A.
    Sturdza, A.
    Schmid, M.
    Heilemann, G.
    Poetter, R.
    Nesvacil, N.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S115 - S116
  • [39] APPLYING THE GLOBAL PATIENT-REPORTED OUTCOME MEASURE TO THE RESULTS OF A CLINICAL TRIAL
    Wiedmeyer, Carole
    Fraenkel, Liana
    Wei, Zhenglin
    Ramsey, Christine
    Michaud, Kaleb D.
    Neogi, Tuhina
    Nowell, William
    Venkatachalam, Shilpa
    Broniatowski, David
    MEDICAL DECISION MAKING, 2020, 40 (01) : E26 - E27
  • [40] Evaluation of the patient-reported outcome (PRO) content of clinical trial protocols
    Kyte, Derek
    Duffy, Helen
    Fletcher, Benjamin
    Gheorghe, Adrian
    Mercieca-Bebber, Rebecca L.
    King, Madeleine T.
    Draper, Heather
    QUALITY OF LIFE RESEARCH, 2014, 23 : 54 - 54